The CORRONA Treat to Target Trial: Outcomes and Feasibility in a US Population

Completed · Not applicable

Conditions studied: Rheumatoid Arthritis

In brief

The Treat to Target Trial is a clinical trial available to new and existing CORRONA (Data Collection Program) sites. Subjects are recruited to participate in this 12 month trial examining outcomes and feasibility of implementing a Treat to Target approach, when compared with a control group of subjects treated with usual care.

Key facts

Study ID

NCT01407419

Run by

CorEvitas

People needed

538

Starts

2011-07-01

Expected to finish

2014-07-01

Last updated by the study team

2018-08-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients eligible for the study will be both male and female adult (at least 18 years of age) patients who have a documented diagnosis of RA, are enrolled or willing to be enrolled in the CORRONA registry for the duration of the trial, have signed appropriate informed consent documents, are willing to participate in the trial, are medically appropriate for participation in the opinion of the investigator, and have moderate to severe RA disease activity as defined by CDAI >10.

You may not qualify if…

• Patients under the age of 18
• Women who are pregnant, breastfeeding or planning to become pregnant during the study period.
• Patients with chronic or acute pain condition(s) other than active RA which, in the opinion of the investigator, is likely to confound or interfere with assessments of RA disease activity.
• Functional class IV as defined by the ACR classification of functional status
• Patients receiving a daily dose of prednisone of >10 mg within the 4 weeks prior to enrollment.
• History of positive tuberculin skin test or equivalents that have not received documented treatment for latent tuberculosis (TB).
• Patients with a significant, uncontrolled concomitant illness such as, but not limited to cardiovascular, renal, neurological, endocrinological, gastrointestinal, hepatic, metabolic, pulmonary or lymphatic disease.

Where it is running

• The Center for Rheumatology — Albany, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.